Patents Assigned to IQUR LIMITED
  • Vaccines based on hepatitis B core antigens
    Patent number: 9950050
    Abstract: The invention provides a protein comprising hepatitis B core antigen (HBcAg) with a sugar attached to an e1 loop. The protein may comprise a first and a second copy of HBcAg in tandem, wherein one or both copies of HBcAg has a sugar attached to the e1 loop. The first copy may have a sugar attached to the e1 loop and the second copy may comprise a peptide epitope in the e1 loop. The protein may be used to induce an immune response against the sugar and hence act as a vaccine.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: April 24, 2018
    Assignee: IQUR LIMITED
    Inventors: Michael Anthony Whelan, Robert A. Field, David J. Rowlands
  • INFLUENZA VACCINE
    Publication number: 20130171182
    Abstract: The invention provides a protein comprising a first and a second copy of hepatitis B core antigen (HBcAg) in tandem, in which one or both of the copies of HBcAg comprises influenza virus A surface polypeptide M2 or a fragment thereof in the e1 loop.
    Type: Application
    Filed: October 22, 2010
    Publication date: July 4, 2013
    Applicant: iQUR Limited
    Inventors: Michael Anthony Whelan, William Malcolm Rosenberg, Lucy Phillipa Beales
  • Methods for Genotyping HVC
    Publication number: 20090130649
    Abstract: The present invention relates to methods for differentiating Hepatitis C virus (HCV) group A genotypes from HCV group B genotypes. The invention finds application in determining prognosis, and in the selection of treatment regimes, for patients infected with HCV.
    Type: Application
    Filed: October 21, 2005
    Publication date: May 21, 2009
    Applicant: IQUR LIMITED
    Inventors: Richard Cross, William Malcolm Charles Rosenberg